Asia Pacific Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The Asia Pacific Clinical Nutrition Market would witness market growth of 8.2% CAGR during the forecast period (2020-2026).
Increased prevalence of chronic disorders, and increased numbers of patients using advanced clinical nutrition products, leading towards the growth of the clinical nutrition industry. Increased government R&D investments in health care are also some of the key factors driving the global market for clinical nutrition. The clinical nutrition industry is however hindered by a lack of knowledge and strict regulations. In addition, increased progress in clinical nutrition is expected to offer profitability to global clinical nutrition market players and the growth of various growth opportunities for clinical nutritional products in emerging countries.
Asia-Pacific is expected to grow at the highest growth over the forecast period. The key factors contributing to the growth of the Asia-Pacific clinical nutrition market include a rise in the prevalence of metabolic disorders, an expansion in the geriatric population in the Asia-Pacific region, as well as extensive healthcare spending. The prevalence of diabetes in China is also growing rapidly, which is a major factor in obesity. The actual number of patients diagnosed with metabolic disorders has increased over the last decade, increasing the number of patients diagnosed in the Asia Pacific region.
Most metabolic syndromes lead to situations where the body cannot synthesize non-essential molecules, such as vitamins, amino acids, and several molecules involved in metabolic pathways. Most of these conditions can only be managed with the addition of one or two nutrients. All of these factors are helping the growth of the market. There are, however, few factors that may restrict the market growth.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the Study
Market Segmentation:
By Route of Administration
Increased prevalence of chronic disorders, and increased numbers of patients using advanced clinical nutrition products, leading towards the growth of the clinical nutrition industry. Increased government R&D investments in health care are also some of the key factors driving the global market for clinical nutrition. The clinical nutrition industry is however hindered by a lack of knowledge and strict regulations. In addition, increased progress in clinical nutrition is expected to offer profitability to global clinical nutrition market players and the growth of various growth opportunities for clinical nutritional products in emerging countries.
Asia-Pacific is expected to grow at the highest growth over the forecast period. The key factors contributing to the growth of the Asia-Pacific clinical nutrition market include a rise in the prevalence of metabolic disorders, an expansion in the geriatric population in the Asia-Pacific region, as well as extensive healthcare spending. The prevalence of diabetes in China is also growing rapidly, which is a major factor in obesity. The actual number of patients diagnosed with metabolic disorders has increased over the last decade, increasing the number of patients diagnosed in the Asia Pacific region.
Most metabolic syndromes lead to situations where the body cannot synthesize non-essential molecules, such as vitamins, amino acids, and several molecules involved in metabolic pathways. Most of these conditions can only be managed with the addition of one or two nutrients. All of these factors are helping the growth of the market. There are, however, few factors that may restrict the market growth.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the Study
Market Segmentation:
By Route of Administration
- Oral
- Enteral and
- Parenteral
- Cancer
- Neurological Diseases
- Gastrointestinal Disorders
- Metabolic Disorders and
- Other Applications
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Nestle S.A.
- Lonza Group AG
- BASF SE
- Ajinomoto Co., Inc.
- Perrigo Company PLC
- Hero Nutritionals, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Clinical Nutrition Market, by Route of Administration
1.4.2 Asia Pacific Clinical Nutrition Market, by Application
1.4.3 Asia Pacific Clinical Nutrition Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Jan – 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions: 2016, Mar – 2019, Oct) Leading Players
CHAPTER 4. ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION
4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Enteral Market by Country
4.3 Asia Pacific Parenteral Market by Country
CHAPTER 5. ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION
5.1 Asia Pacific Cancer Market by Country
5.2 Asia Pacific Neurological Diseases Market by Country
5.3 Asia Pacific Gastrointestinal Disorders Market by Country
5.4 Asia Pacific Metabolic Disorders Market by Country
5.5 Asia Pacific Other Applications Market by Country
CHAPTER 6. ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER
6.1 Asia Pacific Adults Clinical Nutrition Market by Country
6.2 Asia Pacific Pediatric Market by Country
6.3 Asia Pacific Geriatric Market by Country
CHAPTER 7. ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY
7.1 China Clinical Nutrition Market
7.1.1 China Clinical Nutrition Market by Route Of Administration
7.1.2 China Clinical Nutrition Market by Application
7.1.3 China Clinical Nutrition Market by End User
7.2 Japan Clinical Nutrition Market
7.2.1 Japan Clinical Nutrition Market by Route Of Administration
7.2.2 Japan Clinical Nutrition Market by Application
7.2.3 Japan Clinical Nutrition Market by End User
7.3 India Clinical Nutrition Market
7.3.1 India Clinical Nutrition Market by Route Of Administration
7.3.2 India Clinical Nutrition Market by Application
7.3.3 India Clinical Nutrition Market by End User
7.4 South Korea Clinical Nutrition Market
7.4.1 South Korea Clinical Nutrition Market by Route Of Administration
7.4.2 South Korea Clinical Nutrition Market by Application
7.4.3 South Korea Clinical Nutrition Market by End User
7.5 Singapore Clinical Nutrition Market
7.5.1 Singapore Clinical Nutrition Market by Route Of Administration
7.5.2 Singapore Clinical Nutrition Market by Application
7.5.3 Singapore Clinical Nutrition Market by End User
7.6 Malaysia Clinical Nutrition Market
7.6.1 Malaysia Clinical Nutrition Market by Route Of Administration
7.6.2 Malaysia Clinical Nutrition Market by Application
7.6.3 Malaysia Clinical Nutrition Market by End User
7.7 Rest of Asia Pacific Clinical Nutrition Market
7.7.1 Rest of Asia Pacific Clinical Nutrition Market by Route Of Administration
7.7.2 Rest of Asia Pacific Clinical Nutrition Market by Application
7.7.3 Rest of Asia Pacific Clinical Nutrition Market by End User
CHAPTER 8. COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Partnerships, Collaborations, and Agreements:
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Geographical Expansions:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.1 Hero Nutritionals, Inc.
8.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Clinical Nutrition Market, by Route of Administration
1.4.2 Asia Pacific Clinical Nutrition Market, by Application
1.4.3 Asia Pacific Clinical Nutrition Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Jan – 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions: 2016, Mar – 2019, Oct) Leading Players
CHAPTER 4. ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION
4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Enteral Market by Country
4.3 Asia Pacific Parenteral Market by Country
CHAPTER 5. ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION
5.1 Asia Pacific Cancer Market by Country
5.2 Asia Pacific Neurological Diseases Market by Country
5.3 Asia Pacific Gastrointestinal Disorders Market by Country
5.4 Asia Pacific Metabolic Disorders Market by Country
5.5 Asia Pacific Other Applications Market by Country
CHAPTER 6. ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER
6.1 Asia Pacific Adults Clinical Nutrition Market by Country
6.2 Asia Pacific Pediatric Market by Country
6.3 Asia Pacific Geriatric Market by Country
CHAPTER 7. ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY
7.1 China Clinical Nutrition Market
7.1.1 China Clinical Nutrition Market by Route Of Administration
7.1.2 China Clinical Nutrition Market by Application
7.1.3 China Clinical Nutrition Market by End User
7.2 Japan Clinical Nutrition Market
7.2.1 Japan Clinical Nutrition Market by Route Of Administration
7.2.2 Japan Clinical Nutrition Market by Application
7.2.3 Japan Clinical Nutrition Market by End User
7.3 India Clinical Nutrition Market
7.3.1 India Clinical Nutrition Market by Route Of Administration
7.3.2 India Clinical Nutrition Market by Application
7.3.3 India Clinical Nutrition Market by End User
7.4 South Korea Clinical Nutrition Market
7.4.1 South Korea Clinical Nutrition Market by Route Of Administration
7.4.2 South Korea Clinical Nutrition Market by Application
7.4.3 South Korea Clinical Nutrition Market by End User
7.5 Singapore Clinical Nutrition Market
7.5.1 Singapore Clinical Nutrition Market by Route Of Administration
7.5.2 Singapore Clinical Nutrition Market by Application
7.5.3 Singapore Clinical Nutrition Market by End User
7.6 Malaysia Clinical Nutrition Market
7.6.1 Malaysia Clinical Nutrition Market by Route Of Administration
7.6.2 Malaysia Clinical Nutrition Market by Application
7.6.3 Malaysia Clinical Nutrition Market by End User
7.7 Rest of Asia Pacific Clinical Nutrition Market
7.7.1 Rest of Asia Pacific Clinical Nutrition Market by Route Of Administration
7.7.2 Rest of Asia Pacific Clinical Nutrition Market by Application
7.7.3 Rest of Asia Pacific Clinical Nutrition Market by End User
CHAPTER 8. COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Partnerships, Collaborations, and Agreements:
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Geographical Expansions:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.1 Hero Nutritionals, Inc.
8.10.1 Company Overview
LIST OF TABLES
TABLE 1 ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– CLINICAL NUTRITION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– CLINICAL NUTRITION MARKET
TABLE 5 MERGERS & ACQUISITIONS – CLINICAL NUTRITION MARKET
TABLE 6 GEOGRAPHICAL EXPANSIONS – CLINICAL NUTRITION MARKET
TABLE 7 ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 CHINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 38 CHINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 39 CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 40 CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 41 CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 42 CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 43 CHINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 44 CHINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 45 JAPAN CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 46 JAPAN CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 47 JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 48 JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 49 JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 50 JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 51 JAPAN CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 52 JAPAN CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 53 INDIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 54 INDIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 55 INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 56 INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 57 INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 INDIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 60 INDIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 61 SOUTH KOREA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 62 SOUTH KOREA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 63 SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 64 SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 65 SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 66 SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 67 SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 68 SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 69 SINGAPORE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 70 SINGAPORE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 71 SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 72 SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 73 SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 74 SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 75 SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 76 SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 77 MALAYSIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 78 MALAYSIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 79 MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 80 MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 81 MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 82 MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 83 MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 84 MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 85 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 86 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 87 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 88 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 89 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 90 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 91 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 92 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 95 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 96 KEY INFORMATION – PFIZER, INC.
TABLE 97 KEY INFORMATION – NESTLE S.A.
TABLE 98 KEY INFORMATION – LONZA GROUP AG
TABLE 99 KEY INFORMATION – BASF SE
TABLE 100 KEY INFORMATION –AJINOMOTO CO., INC.
TABLE 101 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 102 KEY INFORMATION – HERO NUTRITIONALS, INC.
TABLE 1 ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– CLINICAL NUTRITION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– CLINICAL NUTRITION MARKET
TABLE 5 MERGERS & ACQUISITIONS – CLINICAL NUTRITION MARKET
TABLE 6 GEOGRAPHICAL EXPANSIONS – CLINICAL NUTRITION MARKET
TABLE 7 ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 CHINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 38 CHINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 39 CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 40 CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 41 CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 42 CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 43 CHINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 44 CHINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 45 JAPAN CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 46 JAPAN CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 47 JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 48 JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 49 JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 50 JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 51 JAPAN CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 52 JAPAN CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 53 INDIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 54 INDIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 55 INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 56 INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 57 INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 INDIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 60 INDIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 61 SOUTH KOREA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 62 SOUTH KOREA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 63 SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 64 SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 65 SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 66 SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 67 SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 68 SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 69 SINGAPORE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 70 SINGAPORE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 71 SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 72 SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 73 SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 74 SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 75 SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 76 SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 77 MALAYSIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 78 MALAYSIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 79 MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 80 MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 81 MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 82 MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 83 MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 84 MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 85 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
TABLE 86 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
TABLE 87 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 88 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 89 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 90 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 91 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 92 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 95 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 96 KEY INFORMATION – PFIZER, INC.
TABLE 97 KEY INFORMATION – NESTLE S.A.
TABLE 98 KEY INFORMATION – LONZA GROUP AG
TABLE 99 KEY INFORMATION – BASF SE
TABLE 100 KEY INFORMATION –AJINOMOTO CO., INC.
TABLE 101 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 102 KEY INFORMATION – HERO NUTRITIONALS, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, JAN – 2019, DEC) LEADING PLAYERS
FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS: 2016, MAR – 2019, OCT) LEADING PLAYERS
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, JAN – 2019, DEC) LEADING PLAYERS
FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS: 2016, MAR – 2019, OCT) LEADING PLAYERS
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
